The French Academy of Medicine awards the prestigious Charpak-Dubousset Prize for work research on the prevention of bone fractures in robotic surgery by DSG Technology of SpineGuard

The French Academy of Medicine awards the prestigious Charpak-Dubousset Prize for work research on the prevention of bone fractures in robotic surgery by DSG Technology of SpineGuard

Paris and Boulder, Colorado. – () – Regulatory news:

SpineGuard (FR0011464452 – ALSGD) (Paris: ALSGD), an innovative company that uses DSG® (Dynamic Surgical Guidance) sensor technology to secure and simplify the placement of orthopedic implants, today announced that two researchers, surgeon Elie Saghbini and engineer Jamie Da Silva, have been honored for their collaborative work that It was jointly led by ISIR (Institute for Intelligent and Robotic Systems) of the Sorbonne and SpineGuard. The research focused on using SpineGuard’s DSG technology to automatically detect potentially dangerous bone breaches and to immediately stop drilling when approaching the spinal cord or other soft tissue. DSG enabled bone conduction data recorded at the Trousseau Hospital under the direction of Pr. Vialle can also feed automated algorithms.

DSG is based on the local measurement of tissue electrical conductivity in real time without X-ray imaging, with a sensor at the tip of the drilling tool. Its effectiveness has been proven by over 90,000 surgeries worldwide and 20 scientific publications. SpineGuard entered into a collaboration with ISIR in 2017 to apply DSG to surgical robots and enhance their safety, accuracy and independence.

The Charpak-Dubousset Prize was created in 2019 under the umbrella of the Fondation de France, inspired by the collaboration in the technological and medical field of Georges Charpak, Nobel Prize laureate in Physics, and Professor Jean Dubosset, former Head of Pediatric Orthopedics at the Hospital. Saint-Vincent de Paul (Paris, France) and pioneer of the surgical treatment of scoliosis. The clinical, university and industry partnership allowed them to develop a very low dose digital radiation system and 3D reconstruction methods for the human body. The award rewards a physician and a researcher, each awarded a prize by the French National Academy of Medicine, whose joint research consists of a medical application with a fundamental scientific discovery, and overall collaborative and innovative work.

Stephan Peet, Co-Founder and Executive Vice President, SpineGuarddeclare: “This high-level recognition is a great source of pride for the entire SpineGuard team and a major new milestone because it represents further validation from the scientific community of the relevance and potential of our technology as applied to robot-assisted surgery. It comes naturally as support in SpineGuard’s discussions with industry looking at integrating DSG into robotic-assisted surgical platforms.” “

Guillaume Morel, Professor at the Sorbonne and Director of ISIRadded: “After rewarding an experienced and globally recognized duo such as Matthias Fink and Jean-Michel Corrias, this year the Academy decided to honor young and innovative researchers. This promising award rewards interdisciplinary and interdisciplinary research. For three years, Elie Saghbini immersed himself in our robotic laboratory, getting used to our approaches and methods In addition, Jimmy Da Silva spent several hours in the operating room of Pr. Vialle at Trousseau Hospital in order to analyze each surgical gesture.This daily work and dialogue at the interface of different specialties is bearing fruit today and we are happy to share this success with Trousseau Hospital and SpineGuard, one of our partners Strategists.

The algorithms used for bot control and intrusion detection are the property of SpineGuard, Sorbonne University, INSERM, and CNRS. The validation work has received funding from the European Union’s Horizon 2020 Research and Innovation Programme, in the context of the FAROS (Functional Micro-Robotic Surgery) project under Grant Agreement Na101016985.

**************************

SpineGuard Priorities

SpineGuard focuses on the following priorities while investing selectively to stay close to break-even:

  1. Boost business activities with the launch of the DSG-Connect visual interface and partnership with WishBone Medical

  2. Dissemination of DSG digital technology in the field of surgical robotics

  3. Develop a Universal Smart Drill (SUD) incorporating DSG AI

  4. Support ConfiDent with the design and scaling of DSG dental applications

  5. Implementation of the recently signed agreement with Umniah Medical

  6. Signing other strategic partnerships

About SpineGuard®

Founded in 2009 in France and the USA by Pierre Jerome and Stéphane Pete, SpineGuard is an innovative company that uses real-time, radiation-free DSG® (Dynamic Surgical Guidance) sensor technology to secure and simplify the placement of implants in the skeleton. SpineGuard designs, develops and markets medical devices that have been used in more than 90,000 surgical procedures worldwide. Twenty studies published in peer-reviewed scientific journals have demonstrated the multiple benefits that DSG® offers to patients, surgeons, surgical and hospital personnel. Building on these strong fundamentals and several strategic partnerships, SpineGuard has extended its DSG® technology into innovative applications such as the “smart” cervical screw, DSG Connect recording and visualization interface, dental implants, and surgical robots. DSG® was co-invented by Maurice Burleon, PhD, Ciaran Bolger, MD, PhD, and Alan Vankwethim, biomedical engineer. SpineGuard has been involved in many ESG initiatives.

For more information, visit www.spineguard.com

Disclaimer

SpineGuard’s securities may not be offered or sold in the United States because they have not been and will not be registered under the Securities Act or any United States securities laws, and SpineGuard does not intend to make a public offering of its securities in the United States. This is an announcement, not a prospectus, and the information contained therein does not and will not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein in the U.S. Such offer, solicitation, or sale would be unlawful prior to registration or exemption from registration .

#French #Academy #Medicine #awards #prestigious #CharpakDubousset #Prize #work #research #prevention #bone #fractures #robotic #surgery #DSG #Technology #SpineGuard

Leave a Comment

Your email address will not be published. Required fields are marked *